Dynamic nanocomplexes of antibiotics and biofilm-degrading enzymes overcome biofilm tolerance to treat Pseudomonas aeruginosa infections
Pseudomonas aeruginosa biofilms limit antibiotic penetration and protect embedded bacteria, making established infections difficult to treat. To combat the biofilm, administering tobramycin (Tob) with deoxyribonuclease I (DNase) could pair antimicrobial action with biofilm matrix degradation, but their distinct physicochemical properties hinder co-delivery and transport into the biofilm core.…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.